Share Price and Basic Stock Data
Last Updated: November 14, 2025, 11:31 pm
| PEG Ratio | 0.58 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Chemtech Industrial Valves Ltd operates within the engineering sector, specializing in manufacturing industrial valves. The company’s stock price stood at ₹115, with a market capitalization of ₹207 Cr. Over the past fiscal years, Chemtech has demonstrated a notable increase in sales, recording ₹20.42 Cr in Mar 2023, which rose to ₹31.38 Cr in Mar 2024, and further to ₹40.04 Cr in Mar 2025. Quarterly sales figures reflect this upward trend, particularly in Q4 FY 2023, where sales peaked at ₹8.66 Cr. However, fluctuations are apparent, evidenced by a decline to ₹4.08 Cr in Q2 FY 2023. The company’s ability to bounce back is significant, as shown by Q4 FY 2024, where it achieved sales of ₹10.40 Cr. The trailing twelve months (TTM) sales were reported at ₹38.66 Cr, indicating a robust recovery trajectory despite past volatility.
Profitability and Efficiency Metrics
Chemtech’s profitability metrics exhibit a healthy operational framework, with an operating profit margin (OPM) of 33.44% in the latest quarter. This figure is indicative of strong cost management and pricing power within the industry. The net profit for Mar 2025 stood at ₹7.02 Cr, reflecting a significant increase from ₹2.79 Cr in Mar 2023. The company reported an impressive return on equity (ROE) of 10.7% and a return on capital employed (ROCE) of 14.2%, which are favorable relative to typical sector benchmarks. The interest coverage ratio of 29.78x further underscores Chemtech’s capacity to meet its financial obligations, highlighting operational efficiency in generating profits relative to interest expenses. However, challenges remain, such as the cash conversion cycle of 77.94 days, which suggests potential delays in converting inventory into cash, a factor that could impact liquidity.
Balance Sheet Strength and Financial Ratios
The balance sheet of Chemtech Industrial Valves Ltd reflects strong financial health, characterized by zero borrowings as of Mar 2025, which positions the company favorably against its peers often burdened with debt. Reserves have significantly increased to ₹77.89 Cr, a substantial leap from previous years, indicating robust retained earnings and financial stability. The current ratio of 11.57x and a quick ratio of 11.26x reveal a strong liquidity position, suggesting that Chemtech can comfortably cover its short-term liabilities. The price-to-book value (P/BV) ratio stood at 2.02x, indicating that the market values the company at a premium compared to its book value, a reflection of investor confidence in its growth prospects. However, the company’s asset turnover ratio of 0.51% is relatively low, suggesting room for improvement in leveraging its assets for revenue generation.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Chemtech indicates a significant shift in promoter holdings, which declined from 70.10% in Dec 2022 to 38.89% by Mar 2025, raising potential concerns about insider confidence. Meanwhile, public shareholding has increased to 59.20%, reflecting a growing interest from retail investors. Foreign institutional investors (FIIs) have not invested in the company, while domestic institutional investors (DIIs) hold a modest 1.91%. This distribution suggests a reliance on retail investors for liquidity and market support, which can be volatile. The total number of shareholders has risen to 5,837 as of Mar 2025, indicating a broader base of investor interest and participation. The decline in promoter stake, however, may signal to the market a lack of confidence or a strategic shift, warranting close monitoring.
Outlook, Risks, and Final Insight
The outlook for Chemtech Industrial Valves Ltd appears cautiously optimistic, bolstered by strong sales growth and improving profitability metrics. Key strengths include its robust liquidity position, zero debt, and an impressive interest coverage ratio. However, risks such as fluctuating sales figures, particularly in quarterly performance, and a declining promoter stake could impact investor sentiment. Furthermore, the company’s efficiency in managing its cash conversion cycle remains a critical area for improvement. Should the company continue to enhance its operational efficiencies and leverage its strong balance sheet, it could solidify its market position. Conversely, failure to address these operational challenges may hinder growth potential and affect overall investor confidence. Stakeholders should remain vigilant to these dynamics as Chemtech navigates its growth trajectory in the competitive engineering sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Chemtech Industrial Valves Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 221 Cr. | 650 | 1,121/541 | 17.6 | 218 | 0.46 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 27.5 Cr. | 91.6 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 5.80 Cr. | 13.4 | 18.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.62 Cr. | 14.0 | 16.0/10.3 | 5.07 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 57.9 Cr. | 0.62 | 13.9/0.48 | 3.61 | 1.23 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,576.90 Cr | 473.58 | 46.09 | 116.30 | 0.27% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.98 | 4.08 | 3.70 | 8.66 | 5.62 | 4.59 | 10.77 | 10.40 | 10.94 | 8.49 | 8.24 | 12.36 | 9.57 |
| Expenses | 3.37 | 3.63 | 3.55 | 5.99 | 3.75 | 3.66 | 9.23 | 8.98 | 7.81 | 6.23 | 7.13 | 10.95 | 6.37 |
| Operating Profit | 0.61 | 0.45 | 0.15 | 2.67 | 1.87 | 0.93 | 1.54 | 1.42 | 3.13 | 2.26 | 1.11 | 1.41 | 3.20 |
| OPM % | 15.33% | 11.03% | 4.05% | 30.83% | 33.27% | 20.26% | 14.30% | 13.65% | 28.61% | 26.62% | 13.47% | 11.41% | 33.44% |
| Other Income | 0.43 | 0.03 | 0.01 | 0.54 | 0.23 | 0.01 | 0.01 | 0.14 | 0.17 | 0.11 | 1.15 | 1.20 | 1.49 |
| Interest | 0.27 | 0.29 | 0.29 | 0.29 | 0.31 | 0.23 | 0.26 | 0.23 | 0.16 | 0.14 | 0.01 | 0.04 | 0.07 |
| Depreciation | 0.27 | 0.22 | 0.24 | 0.25 | 0.23 | 0.24 | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.25 | 0.26 |
| Profit before tax | 0.50 | -0.03 | -0.37 | 2.67 | 1.56 | 0.47 | 1.05 | 1.09 | 2.91 | 2.00 | 2.02 | 2.32 | 4.36 |
| Tax % | 32.00% | -166.67% | -102.70% | 9.36% | 12.82% | -17.02% | -4.76% | -5.50% | 25.43% | 22.00% | 25.25% | 23.28% | 31.19% |
| Net Profit | 0.33 | 0.02 | 0.01 | 2.43 | 1.36 | 0.55 | 1.09 | 1.15 | 2.18 | 1.56 | 1.50 | 1.78 | 3.01 |
| EPS in Rs | 0.29 | 0.02 | 0.01 | 2.12 | 1.18 | 0.48 | 0.95 | 0.79 | 1.49 | 1.07 | 0.89 | 0.99 | 1.68 |
Last Updated: August 19, 2025, 9:15 pm
Below is a detailed analysis of the quarterly data for Chemtech Industrial Valves Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9.57 Cr.. The value appears to be declining and may need further review. It has decreased from 12.36 Cr. (Mar 2025) to 9.57 Cr., marking a decrease of 2.79 Cr..
- For Expenses, as of Jun 2025, the value is 6.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.95 Cr. (Mar 2025) to 6.37 Cr., marking a decrease of 4.58 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.20 Cr.. The value appears strong and on an upward trend. It has increased from 1.41 Cr. (Mar 2025) to 3.20 Cr., marking an increase of 1.79 Cr..
- For OPM %, as of Jun 2025, the value is 33.44%. The value appears strong and on an upward trend. It has increased from 11.41% (Mar 2025) to 33.44%, marking an increase of 22.03%.
- For Other Income, as of Jun 2025, the value is 1.49 Cr.. The value appears strong and on an upward trend. It has increased from 1.20 Cr. (Mar 2025) to 1.49 Cr., marking an increase of 0.29 Cr..
- For Interest, as of Jun 2025, the value is 0.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.04 Cr. (Mar 2025) to 0.07 Cr., marking an increase of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.25 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.36 Cr.. The value appears strong and on an upward trend. It has increased from 2.32 Cr. (Mar 2025) to 4.36 Cr., marking an increase of 2.04 Cr..
- For Tax %, as of Jun 2025, the value is 31.19%. The value appears to be increasing, which may not be favorable. It has increased from 23.28% (Mar 2025) to 31.19%, marking an increase of 7.91%.
- For Net Profit, as of Jun 2025, the value is 3.01 Cr.. The value appears strong and on an upward trend. It has increased from 1.78 Cr. (Mar 2025) to 3.01 Cr., marking an increase of 1.23 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.68. The value appears strong and on an upward trend. It has increased from 0.99 (Mar 2025) to 1.68, marking an increase of 0.69.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:39 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.31 | 33.47 | 39.07 | 46.89 | 48.05 | 16.67 | 19.56 | 13.92 | 11.49 | 20.42 | 31.38 | 40.04 | 35.27 |
| Expenses | 29.43 | 34.20 | 38.52 | 43.64 | 44.79 | 14.34 | 16.53 | 11.06 | 9.90 | 16.53 | 25.63 | 32.10 | 28.84 |
| Operating Profit | 0.88 | -0.73 | 0.55 | 3.25 | 3.26 | 2.33 | 3.03 | 2.86 | 1.59 | 3.89 | 5.75 | 7.94 | 6.43 |
| OPM % | 2.90% | -2.18% | 1.41% | 6.93% | 6.78% | 13.98% | 15.49% | 20.55% | 13.84% | 19.05% | 18.32% | 19.83% | 18.23% |
| Other Income | 0.72 | 0.38 | 0.13 | 0.23 | 0.15 | 0.20 | 0.24 | 0.14 | 0.18 | 0.99 | 0.39 | 2.63 | 5.22 |
| Interest | 2.22 | 1.96 | 2.14 | 1.98 | 1.90 | 1.46 | 1.32 | 1.36 | 1.36 | 1.13 | 1.03 | 0.38 | 0.18 |
| Depreciation | 0.83 | 1.29 | 1.23 | 1.17 | 1.09 | 1.06 | 1.01 | 0.99 | 1.01 | 0.98 | 0.94 | 0.95 | 1.00 |
| Profit before tax | -1.45 | -3.60 | -2.69 | 0.33 | 0.42 | 0.01 | 0.94 | 0.65 | -0.60 | 2.77 | 4.17 | 9.24 | 10.47 |
| Tax % | 14.48% | 5.28% | 4.83% | 63.64% | 23.81% | -2,300.00% | -3.19% | -4.62% | -6.67% | -0.36% | 0.24% | 24.13% | |
| Net Profit | -1.67 | -3.78 | -2.82 | 0.12 | 0.32 | 0.23 | 0.97 | 0.68 | -0.56 | 2.79 | 4.15 | 7.02 | 7.52 |
| EPS in Rs | -1.45 | -3.29 | -2.45 | 0.10 | 0.28 | 0.20 | 0.84 | 0.59 | -0.49 | 2.43 | 2.84 | 3.91 | 4.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -126.35% | 25.40% | 104.26% | 166.67% | -28.12% | 321.74% | -29.90% | -182.35% | 598.21% | 48.75% | 69.16% |
| Change in YoY Net Profit Growth (%) | 0.00% | 151.74% | 78.86% | 62.41% | -194.79% | 349.86% | -351.64% | -152.46% | 780.57% | -549.47% | 20.41% |
Chemtech Industrial Valves Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 15% |
| 3 Years: | 52% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 49% |
| 3 Years: | 144% |
| TTM: | 58% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 62% |
| 3 Years: | 71% |
| 1 Year: | -61% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 2:56 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86.34 | 44.60 | 251.87 | 79.55 | 34.87 | 73.13 | 46.46 | 135.30 | 80.05 | 113.68 | 68.74 | 103.19 |
| Inventory Days | 55.83 | 36.50 | 31.20 | 21.58 | 20.22 | 103.18 | 135.88 | 118.46 | 213.37 | 82.45 | 105.60 | 43.34 |
| Days Payable | 63.34 | 23.07 | 256.39 | 78.07 | 19.15 | 99.31 | 77.01 | 134.02 | 225.95 | 127.10 | 90.82 | 68.59 |
| Cash Conversion Cycle | 78.83 | 58.03 | 26.67 | 23.07 | 35.94 | 77.00 | 105.34 | 119.75 | 67.47 | 69.04 | 83.52 | 77.94 |
| Working Capital Days | 11.32 | -10.25 | -5.79 | -18.92 | 4.86 | -2.63 | 27.24 | 122.45 | 85.13 | 104.21 | 84.79 | 155.52 |
| ROCE % | 3.01% | -5.71% | -2.28% | 9.96% | 10.54% | 7.51% | 11.52% | 9.59% | 3.53% | 15.88% | 16.00% | 14.19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.42 | 3.51 | 2.43 | -0.49 | 0.60 |
| Diluted EPS (Rs.) | 4.37 | 3.36 | 2.43 | -0.49 | 0.60 |
| Cash EPS (Rs.) | 4.44 | 3.48 | 3.28 | 0.39 | 1.45 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 53.42 | 23.66 | 10.22 | 7.76 | 8.45 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 53.42 | 23.86 | 10.47 | 8.01 | 8.45 |
| Revenue From Operations / Share (Rs.) | 22.32 | 21.44 | 17.78 | 10.01 | 12.11 |
| PBDIT / Share (Rs.) | 5.88 | 4.20 | 4.25 | 1.54 | 2.61 |
| PBIT / Share (Rs.) | 5.35 | 3.55 | 3.40 | 0.66 | 1.75 |
| PBT / Share (Rs.) | 5.15 | 2.85 | 2.42 | -0.52 | 0.57 |
| Net Profit / Share (Rs.) | 3.91 | 2.84 | 2.43 | -0.48 | 0.59 |
| PBDIT Margin (%) | 26.33 | 19.57 | 23.93 | 15.40 | 21.56 |
| PBIT Margin (%) | 23.96 | 16.56 | 19.14 | 6.60 | 14.46 |
| PBT Margin (%) | 23.08 | 13.28 | 13.60 | -5.25 | 4.71 |
| Net Profit Margin (%) | 17.52 | 13.24 | 13.65 | -4.87 | 4.91 |
| Return on Networth / Equity (%) | 7.32 | 11.99 | 23.75 | -6.28 | 7.04 |
| Return on Capital Employeed (%) | 9.95 | 13.13 | 17.95 | 3.75 | 9.48 |
| Return On Assets (%) | 6.73 | 8.12 | 9.86 | -2.09 | 2.55 |
| Long Term Debt / Equity (X) | 0.00 | 0.11 | 0.77 | 1.15 | 1.10 |
| Total Debt / Equity (X) | 0.00 | 0.13 | 0.89 | 1.33 | 1.10 |
| Asset Turnover Ratio (%) | 0.51 | 0.79 | 0.74 | 0.42 | 0.54 |
| Current Ratio (X) | 11.57 | 3.15 | 2.20 | 1.86 | 2.12 |
| Quick Ratio (X) | 11.26 | 2.72 | 1.81 | 1.32 | 1.66 |
| Inventory Turnover Ratio (X) | 5.00 | 5.23 | 3.54 | 2.03 | 1.77 |
| Interest Coverage Ratio (X) | 29.78 | 5.97 | 4.31 | 1.30 | 2.21 |
| Interest Coverage Ratio (Post Tax) (X) | 20.82 | 5.04 | 3.46 | 0.58 | 1.50 |
| Enterprise Value (Cr.) | 128.31 | 164.69 | 27.10 | 26.43 | 17.33 |
| EV / Net Operating Revenue (X) | 3.20 | 5.25 | 1.33 | 2.30 | 1.25 |
| EV / EBITDA (X) | 12.17 | 26.81 | 5.54 | 14.93 | 5.78 |
| MarketCap / Net Operating Revenue (X) | 4.82 | 5.65 | 0.90 | 1.52 | 0.58 |
| Price / BV (X) | 2.02 | 5.12 | 1.58 | 1.96 | 0.84 |
| Price / Net Operating Revenue (X) | 4.83 | 5.65 | 0.90 | 1.52 | 0.58 |
| EarningsYield | 0.03 | 0.02 | 0.15 | -0.03 | 0.08 |
After reviewing the key financial ratios for Chemtech Industrial Valves Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.42. This value is below the healthy minimum of 5. It has increased from 3.51 (Mar 24) to 4.42, marking an increase of 0.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.37. This value is below the healthy minimum of 5. It has increased from 3.36 (Mar 24) to 4.37, marking an increase of 1.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.44. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 4.44, marking an increase of 0.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 53.42. It has increased from 23.66 (Mar 24) to 53.42, marking an increase of 29.76.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 53.42. It has increased from 23.86 (Mar 24) to 53.42, marking an increase of 29.56.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 22.32. It has increased from 21.44 (Mar 24) to 22.32, marking an increase of 0.88.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.88. This value is within the healthy range. It has increased from 4.20 (Mar 24) to 5.88, marking an increase of 1.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.35. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 5.35, marking an increase of 1.80.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.15. This value is within the healthy range. It has increased from 2.85 (Mar 24) to 5.15, marking an increase of 2.30.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.91. This value is within the healthy range. It has increased from 2.84 (Mar 24) to 3.91, marking an increase of 1.07.
- For PBDIT Margin (%), as of Mar 25, the value is 26.33. This value is within the healthy range. It has increased from 19.57 (Mar 24) to 26.33, marking an increase of 6.76.
- For PBIT Margin (%), as of Mar 25, the value is 23.96. This value exceeds the healthy maximum of 20. It has increased from 16.56 (Mar 24) to 23.96, marking an increase of 7.40.
- For PBT Margin (%), as of Mar 25, the value is 23.08. This value is within the healthy range. It has increased from 13.28 (Mar 24) to 23.08, marking an increase of 9.80.
- For Net Profit Margin (%), as of Mar 25, the value is 17.52. This value exceeds the healthy maximum of 10. It has increased from 13.24 (Mar 24) to 17.52, marking an increase of 4.28.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.32. This value is below the healthy minimum of 15. It has decreased from 11.99 (Mar 24) to 7.32, marking a decrease of 4.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.95. This value is below the healthy minimum of 10. It has decreased from 13.13 (Mar 24) to 9.95, marking a decrease of 3.18.
- For Return On Assets (%), as of Mar 25, the value is 6.73. This value is within the healthy range. It has decreased from 8.12 (Mar 24) to 6.73, marking a decrease of 1.39.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.11 (Mar 24) to 0.00, marking a decrease of 0.11.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.13 (Mar 24) to 0.00, marking a decrease of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.51. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For Current Ratio (X), as of Mar 25, the value is 11.57. This value exceeds the healthy maximum of 3. It has increased from 3.15 (Mar 24) to 11.57, marking an increase of 8.42.
- For Quick Ratio (X), as of Mar 25, the value is 11.26. This value exceeds the healthy maximum of 2. It has increased from 2.72 (Mar 24) to 11.26, marking an increase of 8.54.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 5.23 (Mar 24) to 5.00, marking a decrease of 0.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 29.78. This value is within the healthy range. It has increased from 5.97 (Mar 24) to 29.78, marking an increase of 23.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 20.82. This value is within the healthy range. It has increased from 5.04 (Mar 24) to 20.82, marking an increase of 15.78.
- For Enterprise Value (Cr.), as of Mar 25, the value is 128.31. It has decreased from 164.69 (Mar 24) to 128.31, marking a decrease of 36.38.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 3. It has decreased from 5.25 (Mar 24) to 3.20, marking a decrease of 2.05.
- For EV / EBITDA (X), as of Mar 25, the value is 12.17. This value is within the healthy range. It has decreased from 26.81 (Mar 24) to 12.17, marking a decrease of 14.64.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.82. This value exceeds the healthy maximum of 3. It has decreased from 5.65 (Mar 24) to 4.82, marking a decrease of 0.83.
- For Price / BV (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has decreased from 5.12 (Mar 24) to 2.02, marking a decrease of 3.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 5.65 (Mar 24) to 4.83, marking a decrease of 0.82.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chemtech Industrial Valves Ltd:
- Net Profit Margin: 17.52%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.95% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.32% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 20.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 11.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.1 (Industry average Stock P/E: 46.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 17.52%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | 503, 5th Floor, Sunrise Business Park, Mumbai Maharashtra 400604 | investors@chemtechvalves.com http://www.chemtechvalves.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harsh Pradeep Badkur | Chairman & Managing Director |
| Mr. Puneet Pradeep Badkur | WholeTime Director & CFO |
| Mr. Ignatious David Chittatukarakaran Inasu | Whole Time Director |
| Mrs. Manisha Yogesh Lakhani | Ind. Non-Executive Director |
| Mr. Hemant Goyal | Ind. Non-Executive Director |
| Ms. Amita Jain | Addnl.Non Exe.Independent Director |